Cited by 2,120Sexual function and dysfunction studiesUrological Disorders and TreatmentsSexuality, Behavior, and Technology

Oral Sildenafil in the Treatment of Erectile Dysfunction

Goldstein, Irwin, Lue, Tom F., Padma-Nathan, Harin, Rosen, Raymond C., Steers, William D., Wicker, Pierre A.·1998·New England Journal of Medicine

Abstract

Background Sildenafil is a potent inhibitor of cyclic guanosine monophosphate hydrolysis [corrected] in the corpus cavernosum and therefore increases the penile response to sexual stimulation. We evaluated the efficacy and safety of sildenafil, administered as needed in two sequential double-blind studies of men with erectile dysfunction of organic, psychogenic, and mixed causes. Methods In a 24-week dose-response study, 532 men were treated with oral sildenafil (25, 50, or 100 mg) or placebo. In a 12-week, flexible dose-escalation study, 329 different men were treated with sildenafil or placebo, with dose escalation to 100 mg based on efficacy and tolerance. After this dose-escalation study, 225 of the 329 men entered a 32-week, open-label extension study. We assessed efficacy according to the International Index of Erectile Function, a patient log, and a global-efficacy question. Results In the dose-response study, increasing doses of sildenafil were associated with improved erectile function (P values for increases in scores for questions about achieving and maintaining erections were Conclusions Oral sildenafil is an effective, well-tolerated treatment for men with erectile dysfunction.

Integrity signals

Registry

Crossref · 10.1056/nejm199805143382001

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sildenafil is effective (erection with rigidity sufficient for vaginal penetration) after 30-60 minutes from administration.

    “It is effective (erection with rigidity sufficient for vaginal penetration) after 30-60 minutes from administration [17].”

    From Erectile dysfunction and its pharmacology: An overview (2017) · cites this paper as [17]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A.
Affiliations
  • Boston University (US)
  • University of Southern California (US)
  • University of Medicine and Dentistry of New Jersey (US)
  • University of Virginia (US)
  • Pfizer (United States) (US)
Venue
New England Journal of Medicine
Published
1998-05-14
Volume
338
Issue
20
Pages
1397-1404
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W22857079
Cited by
2,120
References
1
Citations by year
2026: 30 · 2025: 36 · 2024: 35 · 2023: 39 · 2022: 36 · 2021: 43 · 2020: 67 · 2019: 42 · 2018: 54 · 2017: 39 · 2016: 61 · 2015: 53 · 2014: 51 · 2013: 53 · 2012: 59
FWCI
105.72
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
  • Social Sciences › Psychology › Clinical Psychology › Sexuality, Behavior, and Technology
Keywords
sildenafil, erectile dysfunction, phosphodiesterase-5 inhibitors, cyclic GMP, dose-response relationship, dose escalation, International Index of Erectile Function, treatment efficacy, drug safety, adverse effects, organic erectile dysfunction, psychogenic erectile dysfunction
MeSH terms
Sildenafil Citrate, Administration, Oral, Adult, Aged, Aged, 80 and over, Coitus, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Erectile Dysfunction, Male, Middle Aged, Phosphodiesterase Inhibitors, Piperazines, Purines, Sulfones, 3',5'-Cyclic-GMP Phosphodiesterases, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review